NCT02269683

Brief Summary

The present randomized controlled trial evaluates the incidence of R1 resections in patients undergoing robotic distal pancreatectomy compared to the laparoscopic technique.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 17, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 21, 2014

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2015

Completed
Last Updated

June 1, 2016

Status Verified

May 1, 2016

First QC Date

October 17, 2014

Last Update Submit

May 31, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • R1 resection rate

    Proportion of patients with complete macroscopic resection, but microscopic residual tumour. Pathological evaluation will be performed by experienced, board-certified pathologists using standardized protocols according to current guidelines. Importantly, pathologists will be blinded for patients treatment group.

    10 days

Study Arms (2)

Robot-assisted

EXPERIMENTAL

Distal pancreatectomy via robot-assisted minimally-invasive approach

Procedure: Robot-assisted distal pancreatectomy

Laparoscopic

ACTIVE COMPARATOR

Distal pancreatectomy via a conventional laparoscopic approach

Procedure: Laparoscopic distal pancreatectomy

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Suspected malignant disease of the pancreas scheduled for distal pancreatectomy
  • Patient eligible for laparoscopic resection
  • ≥ 18 years of age
  • Written informed consent

You may not qualify if:

  • Planned multi-visceral and/or vascular resection
  • Evidence of distant metastases
  • Expected lack of compliance

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Surgery, University Hospital Dresden

Dresden, 01307, Germany

Location

MeSH Terms

Conditions

Pancreatic Neoplasms

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsEndocrine Gland NeoplasmsDigestive System DiseasesPancreatic DiseasesEndocrine System Diseases
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 17, 2014

First Posted

October 21, 2014

Primary Completion

November 1, 2015

Last Updated

June 1, 2016

Record last verified: 2016-05

Locations